Nezulcitinib (TD-0903) is an inhaled, lung-selective pan-Janus kinase (JAK) inhibitor used to study COVID-19-associated acute lung injury and impaired oxygenation.
Molecular Weight:
527.66
CAS Number:
[2412496-23-0]
Formula:
C30H37N7O2
Target:
Others|||JAK
T63709
* VAT and and shipping costs not included. Errors and price changes excepted